RU 486/Mifegyne na Europa
PARIS, July 7 (LSN) - According to a press release from the abortion drug manufacturer Exelgyn, eight countries approved use of RU-486 on Tuesday. Germany, Austria, Belgium, Denmark, Spain, Finland, Greece and the Netherlands registered the drug with the London-based European Medicine Agency. The drug, now called Mifegyne, can be used to abort babies up to seven weeks after conception.
In yet another attempt at disinformation, the drug is being called a "morning-after pill."
LifeSite Daily News - July 7, 1999
Only Germany Legalized the Drug Itself
EUROPE, July 12 (LSN) - In reporting last week that eight European countries legalized the RU-486 abortion pill (now called Mifegyne), the mainstream media neglected to mention that Germany was the only nation which accepted the deadly pill on its own accord. Mifegyne was imposed upon Austria, Belgium, Denmark, Spain, Finland, Greece and Holland by the European Union, which requires that "national laws of member countries be 'homogenized' to communal decisions."
The only members of the European Union spared the abortion drug's imposition were Portugal, Italy, Luxemburg and Ireland since they had enacted specific laws against the drug. The abortion pill was already in use in England, France and Switzerland. According to the Italian news service, ACI Digital, "in April, the French laboratory, which makes the abortion pill, presented a registration request to the European Pharmaceutical Agency for the pill's commercialization in the European countries where it had not been authorized." The European Pharmaceutical Agency granted its approval within 90 days.
LifeSite Daily News - July 12, 1999
Alemania:
protestas contra la venta de la píldora RU-486
Los
planes para permitir la distribución nacional en Alemania de la píldora
El nuevo
gobierno nacional de centro-izquierda en Alemania dio permiso para la distribución
de la píldora el pasado 6 de julio. Anteriormente el gobierno de Helmut Kohl
había negado las peticiones para introducir la RU-486 en el país. Los católicos
han cuestionado la venta de la píldora en Alemania, especialmente cómo su uso
en otros lugares ha dado pie a fuertes discusiones sobre los aspectos éticos
del fármaco. Oficiales de Femagen comentaron que la píldora tiene como
finalidad presentar una alternativa al aborto quirúrgico. Sin embargo, una
diputada del parlamento por los demócratas cristianos, Hannelore Roensch,
observó que el uso de la RU-486 puede ser doloroso y además en ocasiones lleva
a complicaciones que hacen necesaria una intervención médica.
ZENIT, 27
de noviembre de 1999
Mais informação em: http://www.ru486.org/